Career Opportunity

pdx news

PDX pharma awarded SBIR grant from the National Cancer Institute (total of $2.4M) for the development of PETTRA, a novel lung cancer treatment

7/6/2023
read more
CEO of PDX Pharma selected as a semi-finalists at the AIM-HI Women’s Venture Competition in Oncology

5/3/2023
read more
PDX Pharma awarded two-year $1.87M phase II SBIR grant from the National Cancer Institute (NCI) for the development of ARAC-02, a novel lung cancer treatment

2/21/2023
read more